The Next Blockbuster Drug Might Be Made in Space
Microgravity experiments bear fruit. Plus: Seagliders revive dream of carbon-free travel.
The International Space Station.
Photographer: NASA
Welcome to Bw Daily, the Bloomberg Businessweek newsletter, where we’ll bring you interesting voices, great reporting and the magazine’s usual charm every weekday. Let us know what you think by emailing our editor here. If this has been forwarded to you, click here to sign up.
Startup LambdaVision Inc. has big plans to develop the world’s first protein-based artificial retina for patients with retinitis pigmentosa, a genetic cause of blindness. Manufacturing the retina involves depositing 200 paper-thin layers of a light-sensitive protein in a polymer mesh. The protein layers must be perfectly even for the retina to work properly, a process that’s hard to get right on Earth.